BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present at the Ophthalmology Innovation Summit (OIS) at AAO on October 16th, 2014 at 11:35 AM. Dr. Sawhney will also sit on the panel IPOs in Ophthalmology – The Class of 2014 And Beyond at 4:10 PM. The Ophthalmology Innovation Summit will take place at the Palmer House Hilton in Chicago, IL.
Help employers find you! Check out all the jobs and post your resume.
